Membrane-bound and exosomal metastasis-associated C4.4A promotes migration by associating with the α6β4 integrin and MT1-MMP1,2

Neoplasia

Volumn 14, Issue 2, 2012, Pages 95-107

  Ngora, Honoré ^c   Galli, Uwe M ^c,d   Miyazaki, Kaoru ^a   Zöller, Margot ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6BETA4 INTEGRIN; C4.4A PROTEIN; GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KALININ; LAMININ; MATRIX METALLOPROTEINASE 14; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; EXOSOME; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KERATINOCYTE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; WOUND HEALING;

EID: 84858032415     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.111450     Document Type: Article

References (74)

1. Rösel M, Claas C, Seiter S, Herlevsen M, and Zöller M (1998). Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumor. Oncogene 17, 1989-2002.
2. Würfel J, Rösel M, Seiter S, Claas C, Herlevsen M, Weth R, and Zöller M (2001). Cloning of the human homologue of the metastasis-associated rat C4.4A. Gene 262, 35-41.
3. Jacobsen B and Ploug M (2008). The urokinase receptor and its structural homologue C4.4A in human cancer: expression, prognosis and pharmacological inhibition. Curr Med Chem 15, 2559-2573.
4. Tsetlin V (1999). Snake venom a-neurotoxins and other "three-finger" proteins. Eur J Biochem 264, 281-286.
5. Fry BG (2005). From genome to "venome": molecular origin and evolution of the snake venom proteome inferred from phylogenetic analysis of toxin sequences and related body proteins. Genome Res 15, 403-420.
6. Galat A (2008). The three-fingered protein domain of the human genome. Cell Mol Life Sci 65, 3481-3493.
7. Hansen LV, Gardsvoll H, Nielsen BS, Lund LR, Jensen ON, and Ploug M (2004). Structural analysis and tissue localization of human C4.4A: a protein homologue of the urokinase receptor. Biochem J380, 845-857.
8. Paret C, Bourouba M, Beer A, Miyazaki K, Schnölzer M, Fiedler S, and Zöller M (2005). Ly6 family member C4.4A binds laminins 1 and 5 associates with galectin-3 and supports cell migration. IntJ Cancer 115, 724-733.
9. Claas C, Herrmann K, Matzku S, Möller P, and Zöller M (1996). Developmen-tally regulated expression of metastasis-associated antigens in the rat. Cell Growth Differ 7, 663-678.
10. Smith BA, Kennedy WJ, Harnden P, Selby PJ, Trejdosiewicz LK, and Southgate J (2001). Identification of genes involved in human urothelial cell-matrix interactions: implications for the progression pathways of malignant urothelium. Cancer Res 61, 1678-1685.
11. Paret C, Hildebrand D, Weitz J, Kopp-Schneider A, Kuhn A, Beer A, Hautmann R, and Zöller M (2007). C4.4A as a candidate marker in the diagnosis of colorectal cancer. Br J Cancer 97, 1146-1156.
12. Seiter S, Stassar M, Rappl G, Reinhold U, Tilgen W, and Zöller M (2001). Upregulation of C4.4A expression during progression of melanoma. J Invest Dermatol 116, 344-347.
13. Fletcher GC, Patel S, Tyson K, Adam PJ, Schenker M, Loader JA, Daviet L, Legrain P, Parekh R, Harris AL, et al. (2003). hAG-2 and hAG-3 human homo-logues of genes involved in differentiation are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan. Br J Cancer 88, 579-585.
14. Hansen LV, Skov BG, Ploug M, and Pappot H (2007). Tumour cell expression of C4.4A, a structural homologue of the urokinase receptor, correlates with poor prognosis in non-small cell lung cancer. Lung Cancer 58, 260-266.
15. Hansen LV, Laerum OD, Illemann M, Nielsen BS, and Ploug M (2008). Altered expression of the urokinase receptor homologue, C4.4A, in invasive areas of human esophageal squamous cell carcinoma. Int J Cancer 122, 734-741.
16. Wang W, Ding YQ, Li ZG, Han HX, and Yang L (2006). Expression and diagnostic application of C4.4A protein in squamous cell carcinoma and adeno-carcinoma [in Chinese]. Zhonghua Bing Li Xue Za Zhi 35, 277-280.
17. Fries F, Nazarenko I, Hess J, Claas A, Angel P, and Zöller M (2007). CEBPβ, JunD and c-Jun contribute to the transcriptional activation of the metastasis-associated C4.4A gene. Int J Cancer 120, 2135-2147.
18. Meir O, Dvash E, Werman A, and Rubinstein M (2010). C/EBP-β regulates endoplasmic reticulum stress-triggered cell death in mouse and human models. PLoS One 5, e9516.
19. Staiger J, Lueben MJ, Berrigan D, Malik R, Perkins SN, Hursting SD, and Johnson PF (2009). C/EBPβ regulates body composition, energy balance-related hormones and tumor growth. Carcinogenesis 30, 832-840.
20. Kirstetter P, Schuster MB, Bereshchenko O, Moore S, Dvinge H, Kurz E, Theilgaard-Mönch K, Månsson R, Pedersen TA, Pabst T, et al. (2008). Modeling of C/EBPα mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. Cancer Cell 13, 299-310.
21. Franco-Montoya ML, Bourbon JR, Durrmeyer X, Lorotte S, Jarreau PH, and Delacourt C (2009). Pulmonary effects of keratinocyte growth factor in newborn rats exposed to hyperoxia. Am J Physiol Lung Cell Mol Physiol 297, L965-L976.
22. 5 expression through CCAAT/enhancer-binding protein-β. Am J Physiol Cell Physiol 293, C1020-C1031.
23. Tandara AA and Mustoe TA (2004). Oxygen in wound healing-more than a nutrient. World J Surg 28, 294-300.
24. Finger EC and Giaccia AJ (2010). Hypoxia, inflammation, and the tumor micro-environment in metastatic disease. Cancer Metastasis Rev 29, 285-293.
25. Fitsialos G, Bourget I, Augier S, Ginouvès A, Rezzonico R, Odorisio T, Cianfarani F, Virolle T, Pouysségur J, Meneguzzi G, et al. (2008). HIF1 transcription factor regulates laminin-332 expression and keratinocyte migration. J Cell Sci 121, 2992-3001.
26. Yee Koh M, Spivak-Kroizman TR, and Powis G (2008). HIF-1 regulation: not so easy come, easy go. Trends Biochem Sci 33, 526-534.
27. Kaluz S, Kaluzová M, and Stanbridge EJ (2008). Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element. Clin Chim Acta 395, 6-13.
28. Brahimi-Horn MC and Pouysségur J (2009). HIF at a glance. J Cell Sci 122, 1055-1057.
29. Matzku S, Komitowski D, Mildenberger M, and Zöller M (1983). Characterization of BSp73 a spontaneous rat tumor and its in vivo selected variants showing different metastasizing capacities. Invasion Metastasis 3, 109-123.
30. Martin F, Caignard A, Jeannin JF, Leclerc A, and Martin M (1983). Selection by trypsin of two sublines of rat colon cancer cells forming progressive or regressive tumors. Int J Cancer 32, 623-627.
31. Homma Y, Ozono S, Numata I, Seidenfeld J, and Oyasu R (1985). α-Difluoro-methylornithine inhibits cell growth stimulated by a tumor-promoting rat urinary fraction. Carcinogenesis 6, 159-161.
32. Panneerselvam M, Sahai A, and Salomon DS (1985). Modulation of type-IV procollagen and laminin production in A431 human squamous epidermoid carcinoma cells by 12-O-tetradecanoylphorbol-13-acetate (TPA) and epidermal growth factor (EGF). Arch Dermatol Res 277, 377-383.
33. Takamori H, Hiraoka T, and Yamamoto T (1996). Expression of tumor-associated carbohydrate antigens correlates with hepatic metastasis of pancreatic cancer: clinical and experimental studies. Hepatogastroenterology 43, 748-755.
34. Morgan RT, Woods LK, Moore GE, Quinn LA, McGarvan L, and Gordon SG (1980). Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma. Int J Cancer 25, 591-598.
35. Tan MH, Nowak NJ, Loor R, Ochi H, Sandberg AA, Lopez C, Pickren JW, Berjian R, Douglass HO Jr, and Chu TM (1986). Characterization of a new primary human pancreatic tumor line. Cancer Invest 4, 15-23.
36. Luckow B and Schütz G (1987). CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements. Nucleic Acids Res 15, 5490.
37. Burger HJ, Schuetz JD, Schuetz EG, and Guzelian PS (1992). Paradoxical tran-scriptional activation of rat liver cytochrome P-450 3A1 by dexamethasone and the antiglucocorticoid pregnenolone 16 α-carbonitrile: analysis by transient trans-fection into primary monolayer cultures of adult rat hepatocytes. Proc Natl Acad Sci USA 89, 2145-2149.
38. Gorman CM, Moffat LF, and Howard BH (1982). Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol 2, 1044-1051.
39. Liu XH, Kirschenbaum A, Yao S, Stearns ME, Holland JF, Claffey K, and Levine AC (1999). Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis 17, 687-694.
40. Rabinovitz I and Mercurio AM (1996). The integrin α6β4 and the biology of carcinoma. Biochem Cell Biol 74, 811-821.
41. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, and Quaranta V (1997). Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277, 225-228.
42. Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, and Quaranta V (2000). Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 148, 615-624.
43. Udayakumar TS, Chen ML, Bair EL, Von Bredow DC, Cress AE, Nagle RB, and Bowden GT (2003). Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 β3 chain and induces cell migration. Cancer Res 63, 2292-2299.
44. Jung T, Castellana D, Klingbeil P, Cuesta Hernández I, Vitacolonna M, Orlicky DJ, Roffler SR, Brodt P, and Zöller M (2009). CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia 11, 1093-1105.
45. Gårdsvoll H, Hansen LV, Jørgensen TJ, and Ploug M (2007). A new tagging system for production of recombinant proteins in Drosophila S2 cells using the third domain of the urokinase receptor. Protein Expr Purif 52, 384-394.
46. Chun KS and Surh YJ (2004). Signal transduction pathways regulating cyclo-oxygenase-2 expression: potential molecular targets for chemoprevention. Biochem Pharmacol 68, 1089-1100.
47. Maytin EV, Lin JC, Krishnamurthy R, Batchvarova N, Ron D, Mitchell PJ, and Habener JF (1999). Keratin 10 gene expression during differentiation of mouse epidermis requires transcription factors C/EBP and AP-2. Dev Biol 216, 164-181.
48. House JS, Zhu S, Ranjan R, Linder K, and Smart RC (2010). C/EBPα and C/ EBPβ are required for sebocyte differentiation and stratified squamous differentiation in adult mouse skin. PLoS One 5, e9837.
49. Kariya Y, Kariya Y, and Gu J (2009). Roles of laminin-332 and α6β4 integrin in tumor progression. Mini Rev Med Chem 9, 1284-1291.
50. Frijns E, Sachs N, Kreft M, Wilhelmsen K, and Sonnenberg A (2010). EGF-induced MAPK signaling inhibits hemidesmosome formation through phosphoryla-tion of the integrin β4. J Biol Chem 285, 37650-37662.
51. Lipscomb EA and Mercurio AM (2005). Mobilization and activation of a signaling competent α6β4 integrin underlies its contribution to carcinoma progression. Cancer Metastasis Rev 24, 413-423.
52. Litjens SH, de Pereda JM, and Sonnenberg A (2006). Current insights into the formation and breakdown of hemidesmosomes. Trends Cell Biol 16, 376-383.
53. Soung YH, Gil HJ, Clifford JL, and Chung J (2011). Role of α6β4 integrin in cell motility, invasion and metastasis of mammary tumors. Curr Protein Pept Sci 12, 23-29.
54. Streuli CH and Akhtar N (2009). Signal co-operation between integrins and other receptor systems. Biochem J 418, 491-506.
55. Merdek KD, Yang X, Taglienti CA, Shaw LM, and Mercurio AM (2007). Intrinsic signaling functions of the β4 integrin intracellular domain. J Biol Chem 282, 30322-30330.
56. Yang X, Kovalenko OV, Tang W, Claas C, Stipp CS, and Hemler MH (2004). Palmitoylation supports assembly and function of integrin-tetraspanin complexes. J Cell Biol 167, 1231-1240.
57. Giancotti FG (2007). Targeting integrin β4 for cancer and anti-angiogenic therapy. Trends Pharmacol Sci 28, 506-511.
58. LaFlamme SE, Homan SM, Bodeau AL, and Mastrangelo AM (1997). Integrin cytoplasmic domains as connectors to the cell's signal transduction apparatus. Matrix Biol 16, 153-163.
59. Yang X, Dutta U, and Shaw LM (2010). SHP2 mediates the localized activation of Fyn downstream of the α6β4 integrin to promote carcinoma invasion. Mol Cell Biol 30, 5306-5317.
60. Gagnoux-Palacios L, Dans M, van't Hof W, Mariotti A, Pepe A, Meneguzzi G, Resh MD, and Giancotti FG (2003). Compartmentalization of integrin α6β4 signaling in lipid rafts. J Cell Biol 162, 1189-1196.
61. Pankov R, Endo Y, Even-Ram S, Araki M, Clark K, Cukierman E, Matsumoto K, and Yamada KM (2005). A Rac switch regulates random versus directionally persistent cell migration. J Cell Biol 170, 793-802.
62. 4 Integrin and epidermal growth factor coordinately regulate electric field-mediated directional migration via Rac1. Mol Biol Cell 17, 4925-4935.
63. Marinkovich MP, Lunstrum GP, and Burgeson RE (1992). The anchoring filament protein kalinin is synthesized and secreted as a high molecular weight precursor. J Biol Chem 267, 17900-17906.
64. Schenk S, Hintermann E, Bilban M, Koshikawa N, Hojilla C, Khokha R, and Quaranta V (2003). Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol 161, 197-209.
65. 2 chain plays a pivotal role in the incorporation of laminin 5 into the extracellular matrix and in cell adhesion. J Cell Biol 153, 835-850.
66. Sigle RO, Gil SG, Bhattacharya M, Ryan MC, Yang TM, Brown TA, Boutaud A, Miyashita Y, Olerud J, and Carter WG (2004). Globular domains 4/5 of the laminin 0C3 chain mediate deposition of precursor laminin 5. J Cell Sci 117, 4481-4494.
67. Tripathi M, Nandana S, Yamashita H, Ganesan R, Kirchhofer D, and Quaranta V (2008). Laminin-332 is a substrate for hepsin, a protease associated with prostate cancer progression. J Biol Chem 283, 30576-30584.
68. Ogura Y, Matsunaga Y, Nishiyama T, and Amano S (2008). Plasmin induces degradation and dysfunction of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal junction. Br J Dermatol 159, 49-60.
69. Esselens CW, Malapeira J, Colomé N, Moss M, Canals F, and Arribas J (2008). Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17. Biol Chem 389, 1075-1084.
70. Simons M and Raposo G (2009). Exosomes-vesicular carriers for intercellular communication. Curr Opin Cell Biol 21, 575-581.
71. Staubach S, Razawi H, and Hanisch FG (2009). Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7. Proteomics 9, 2820-2835.
72. Jiang A, Lehti K, Wang X, Weiss SJ, Keski-Oja J, and Pei D (2001). Regulation of membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis. Proc Natl Acad Sci USA 98, 13693-13698.
73. Escrevente C, Morais VA, Keller S, Soares CM, Altevogt P, and Costa J (2008). Functional role of N-glycosylation from ADAM10 in processing, localization and activity of the enzyme. Biochim Biophys Acta 1780, 905-913.
74. Hakulinen J, Sankkila L, Sugiyama N, Lehti K, and Keski-Oja J (2008). Secretion of active membrane type 1 matrix metalloproteinase (MMP-14) into extracellular space in microvesicular exosomes. J Cell Biochem 105, 1211-1218.